Incyte (INCY -2.8%) trades lower after Citi cuts the shares the shares to Neutral from Buy. Citi...

|About: Incyte Corporation (INCY)|By:, SA News Editor

Incyte (INCY -2.8%) trades lower after Citi cuts the shares the shares to Neutral from Buy. Citi cites limited market potential for Jakafi after conducting a survey that showed only 35% of physicians were expected to prescribe the drug to their patients.